30.08.2011 • NewsMerck & Co.PeopleKenneth Frazier

Richard DeLuca Named President, Merck Animal Health

Merck & Co. said it appointed Richard DeLuca Jr. as executive vice president and president, Merck Animal Health, effective Sept. 15. DeLuca will report to Kenneth Frazier, Merck's president and chief executive, and would serve on the company's executive committee.

DeLuca is succeeding Raul Kohan, who has decided to retire from the company. Kohan will remain with the company until the end of the year. Merck noted that DeLuca would leverage the division's strong product portfolio and customer focus to capitalize on new growth opportunities, including expanding the business in emerging markets.

DeLuca has served as chief financial officer of BD Biosciences since 2010.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read